
M3541
CAS No. 1360628-91-6
M3541( —— )
Catalog No. M36357 CAS No. 1360628-91-6
M3541 is a selectively potent and orally active ATM inhibitor with potential antitumor activity.M-3541 inhibits ATM kinase activity and ATM-mediated signaling by binding to ATM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 787 | Get Quote |
![]() ![]() |
5MG | 1112 | Get Quote |
![]() ![]() |
25MG | 1766 | Get Quote |
![]() ![]() |
50MG | 2190 | Get Quote |
![]() ![]() |
100MG | 2790 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameM3541
-
NoteResearch use only, not for human use.
-
Brief DescriptionM3541 is a selectively potent and orally active ATM inhibitor with potential antitumor activity.M-3541 inhibits ATM kinase activity and ATM-mediated signaling by binding to ATM.
-
DescriptionDNA-PK-IN-11 is a DNA-PK inhibitor with an IC50 of <0.1 μM (DE102010035744A1; compound 36).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis | ATM/ATR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1360628-91-6
-
Formula Weight428.42
-
Molecular FormulaC23H17FN6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (11.67 mM; Ultrasonic (<60°C)
-
SMILESO=C1N(C=2C=3C(=CC(OC)=C(C3)C4=CN(C)N=C4)N=CC2N1C)C5=C(F)C=C(C#N)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dr. Fuchss Thomas, et al. Imidazolonylchinoline. DE102010035744A1.
molnova catalog



related products
-
Rigosertib
Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 (IC50: 9 nM).
-
D609
D609 (Tricyclodecan-9-yl-Xanthogenate) has a wide range of biological activities including antioxidant, antiapoptotic, anticholinergic, antitumor, anti-inflammatory, antiviral, antiproliferative, and neuroprotective activities.
-
LYG-202
LYG-202 is a novel flavonoid with piperazine substitution and antitumor effects in vivo and in vitro.LYG-202 induced apoptosis in MCF-7, MDA-MB-231, and MDA-MB-435 cells, and increased intracellular ROS production.